Emerald Health Therapeutics Names DDB Canada Agency of Record
April 20 2018 - 7:00AM
Emerald Health Therapeutics Inc. (“Emerald”) (TSX-V:EMH)
(OTCQX:EMHTF) today announced DDB Canada’s Vancouver office its
agency of record (AOR) following a national search managed by
Reynolds & Fyshe. As agency of record, DDB Canada Vancouver and
its integrated suite of marketing specialist disciplines, Twice,
TRACKDDB, DDB Public Relations, TracyLocke Canada and Tribal
Worldwide, will be providing a full range of seamlessly integrated
communications services.
Committed to an exclusive partnership within the
cannabis category, the agency’s work will be designed to launch
various brand initiatives and scale Emerald’s marketing
communications efforts based on both domestic and global growth
plans. The agency has already commenced work to support Emerald
Health’s multi-phase expansion plans. The company plans to scale
its offerings to meet the anticipated demand for a new, legalized
recreational cannabis market following adult-use legalization
across Canada slated for summer 2018.
“We were looking for a global, top-tier agency
to suit Emerald Health’s broad scope of aspirations both in Canada
and abroad,” says Paul Dillman, VP Marketing and Sales, Emerald
Health. “DDB was the perfect fit with their world-class
strategic approach, resources to support our global expansion and a
deep understanding and knowledge of the Canadian market, including
Quebec.”
“DDB Canada is selective in pursuing symbiotic
partnerships with reputable, like-minded companies and Emerald
Health’s science-based approach and focus on innovation makes them
the perfect partner,” says Patty Jones, EVP Managing Director, DDB
Canada Vancouver. “It’s an exciting opportunity to bring Emerald
Health’s mission, vision and brand to life - all while serving as
an extension of the company as its brand steward. We look forward
to working hand-in-hand with its key decision makers to build this
brand, while adapting and pivoting when needed as regulations in
the industry evolve.”
About DDB Canada
DDB Canada is the most creatively acclaimed,
internationally recognized marketing communications agency in
Canada. The agency was named 2015 Digital Agency of the Year
by strategy magazine and was ranked #2 agency in Canada by the Gunn
Report in 2015. Known for advertising that generates
significant results for clients, DDB Canada is a "total
communications company" whose fundamental belief is that creativity
is the most powerful force in business. DDB Canada has offices in
Vancouver, Edmonton, Toronto and Montreal. The agency's integrated
marketing disciplines include: public relations, event management,
digital, social, mobile, branding, design, direct response, CRM and
shopper marketing.
About Emerald Health Therapeutics
Inc.
Emerald Health Therapeutics, Inc. (TSX-V:EMH)
(OTCQX:EMHTF) operates through Emerald Health Botanicals Inc.
("Botanicals"), a wholly owned subsidiary and Licensed Producer
under Canada’s Access to Cannabis for Medical Purposes Regulations.
Through Botanicals, Emerald is authorized to produce and sell dried
medical cannabis flower and medical cannabis oil. It currently
operates an indoor facility in Victoria, BC, and is building a
500,000 s.f. greenhouse on 32 acres in Metro Vancouver, with
expansion potential to 1 million s.f. to serve the anticipated
legal Canadian adult-use cannabis market starting in 2018. Emerald
also owns 50% of Pure Sunfarms, a partnership with Village Farms
that is converting an existing 1.1 million s.f. greenhouse in
Delta, BC from growing tomatoes to growing cannabis. Emerald’s team
is highly experienced in life sciences, product development and
large-scale agribusiness. Emerald is part of the Emerald Health
group, which is broadly focused on developing pharmaceutical,
botanical and nutraceutical products designed to provide wellness
and medical benefits by interacting with the human body’s
endocannabinoid system. Please visit www.emeraldhealth.ca for more
information.
Contacts:
Rob Hill, Chief Financial Officer (800)
757 3536 Ext. #5
Ray Lagace, Investor Relations Manager(800) 757
3536 Ext. #5invest@emeraldhealth.ca
Paige Calvert, Director of Corporation
Communications, DDB Canada(604) 608
4421paige.calvert@ddbcanada.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking
Statements: Certain statements made in this press release that are
not historical facts are forward-looking statements and are subject
to important risks, uncertainties and assumptions, both general and
specific, which give rise to the possibility that actual results or
events could differ materially from our expectations expressed in
or implied by such forward-looking statements. Such statements
include completion of the joint venture; establishing a brand;
sales of non-cannabis products; development of sales channels;
expansion of permitted sales of cannabis; leveraging of
distribution channels; development of new products; the benefits
and effects of certain products.
We cannot guarantee that any forward-looking
statement will materialize and readers are cautioned not to place
undue reliance on these forward looking statements. These
forward-looking statements involve risks and uncertainties related
to, among other things, failure to obtain regulatory approvals;
failure to obtain necessary financing; results of production and
sale activities; results of scientific research; regulatory
changes; availability of products; changes in prices and costs;
demand for products; as well as the risk factors described in the
Company’s annual information form and other regulatory filings. The
forward-looking statements contained in this press release
represent our expectations as of the date hereof. Forward-looking
statements are presented for the purpose of providing information
about management's current expectations and plans and allowing
investors and others to obtain a better understanding of our
anticipated operating environment. Readers are cautioned that such
information may not be appropriate for other purposes. The Company
undertakes no obligations to update or revise such statements to
reflect new circumstances or unanticipated events as they occur,
unless required by applicable law.
Emerald Health Therapeut... (TSXV:EMH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emerald Health Therapeut... (TSXV:EMH)
Historical Stock Chart
From Apr 2023 to Apr 2024